您的評論: The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

Aims Cachexia, the wasting disorder associated with a wide range of serious illnesses including cancer, is a major cause of morbidity and mortality. There is currently no widely approved therapeutic agent for treating or preventing cancer-associated cachexia. Colorectal cancer and nonsmall cell l...

全面介紹

Saved in:

書目詳細資料
Main Authors:	Stewart Coats, Andrew J., Srinivasan, Venkatesan, Surendran, Jayaraman, Chiramana, Haritha, Vangipuram, Shankar R. K. G., Bhatt, Nirajkumar N., Jain, Minish, Shah, Sandip, Ali, Irfhan A. B. H., Fuang, Ho G., Mat Hassan, Mohd. Zailani, Beadle, John, Tilson, Julia, Kirwan, Bridget-Anne, Anker, Stefan D.
格式:	Article
語言:	English
出版:	Springer 2011
主題:	R Medicine (General)
在線閱讀:	http://irep.iium.edu.my/18416/1/13539_2011_Article_46.pdf http://irep.iium.edu.my/18416/ http://dx.doi.org/10.1007/s13539-011-0046-2
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

成為第一個發表評論!

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

相似書籍